 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: IONIS-FXI-LRx
                                 Compound class: 
                                                            Nucleic acid
                                 
                                    
                                        Comment: Fesomersen (IONIS-FXI-LRx) is a conjugated antisense oligonucleotide that selectively inhibits the expression of factor XI [1]. It is being explored as an anticoagulation therapy. We provide the basic nucleotide sequence, without the modifications outlined in the INN record for this drug. | 
| No information available. | 
| Summary of Clinical Use  | 
| Fesomersen is being investigated as an anticoagulation therapy. | 
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References | 
| NCT03582462 | A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of IONIS FXI-LRx in up to 84 Healthy Volunteers | Phase 1 Interventional | Ionis Pharmaceuticals, Inc. | ||